RHAPSODY: Rationale for and Design of a Pivotal Phase 3 Trial to Assess Efficacy and Safety of Rilonacept, an IL-1α and IL-1β trap, in Patients with Recurrent Pericarditis

Publication date: Available online 14 July 2020Source: American Heart JournalAuthor(s): Allan Klein, Massimo Imazio, Antonio Brucato, Paul Cremer, Martin LeWinter, Antonio Abbate, David Lin, Alberto Martini, Anna Beutler, Steven Chang, Fang Fang, Anais Gervais, Randy Perrin, John F. Paolini
Source: American Heart Journal - Category: Cardiology Source Type: research